12 Results for "

neuronal hyperexcitability

" in MedChemExpress (MCE) Product Catalog:
Products (12)

12 Results for "neuronal hyperexcitability" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-147423
CAS No.: 2154406-04-7
Purity:  99.28%
Synonyms: NBI-921352; XEN901
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

Zandatrigine (NBI-921352; XEN901) is a selective, orally active, voltage-gated sodium channel NaV1.6/SCN8A inhibitor that can penetrate the blood-brain barrier. Zandatrigine inhibits sodium influx by non-covalently binding to the VSD4 structure of NaV1.6, blocking the persistent and resuscitative currents under pathological conditions. Zandatrigine can reduce neuronal hyperexcitability and reduce epileptic seizures. Zandatrigine is 134-756-fold selective for other isoforms such as NaV1.1 and NaV1.2, and has minimal effect on NaV1.1 expressed by inhibitory interneurons. Zandatrigine can be used to study NaV1.6-mediated neuroexcitability diseases such as SCN8A-related developmental epileptic encephalopathy (SCN8A-DEE) and adult focal epilepsy .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-15416
CAS No.: 18711-16-5
Purity:  99.09%
NS309 is a potent and selective activator of the Ca 2+-activated SK/IK potassium channels, but displays no activity at BK channels .
loading...
    loading...
Cat. No.: HY-A0042
CAS No.: 106308-44-5
Synonyms: CGP 33101; E 2080; RUF 331
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

Rufinamide (CGP 33101) is an orally active antiepileptic compound that inhibits Na + current activation, inhibits neuronal hyperexcitability, and has anticonvulsant effects. Rufinamide is used in the study of Lennox-Gastaut syndrome .
loading...
    loading...
Cat. No.: HY-110162
CAS No.: 1259536-62-3
Purity:  99.01%
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

QO 58 is a potent modulator of K(v)7 channels. QO-58 increases the current amplitudes, shifts the voltage-dependent activation curve in a more negative direction and slows the deactivation of K(v)7.2/K(v)7.3 currents. QO-58 has the potential for the research of diseases associated with neuronal hyperexcitability .
loading...
    loading...
Cat. No.: HY-123264
CAS No.: 1919050-87-5
Purity:  99.20%
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

RL648_81 is a specific KQT-like subfamily 2/3 (KCNQ2/3) activator with an EC50 of 190 nM. RL648_81 robustly shifts the V1/2 of KCNQ2/3 channels towards hyperpolarized potentials.RL648_81 does not shift the V1/2 of either KCNQ4 or KCNQ5.RL648_81 has?the?potential?for?neurologic disorders associated with neuronal hyperexcitability research .
loading...
    loading...
Cat. No.: HY-174146
CAS No.: 2410053-15-3
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

5-HT1A agonist 1 (Compound Ex.37) is a highly selective 5-HT1a receptor agonist (EC50=0.18 nM). 5-HT1A agonist 1 mimicks serotonin binding to the receptor, promotes postsynaptic membrane hyperpolarization, inhibits neuronal hyperexcitability, and reduces the release of anxiety-related neurotransmitters. 5-HT1A agonist 1 is promising for research of neuropsychiatric diseases .
loading...
    loading...
Cat. No.: HY-A0042R
CAS No.: 106308-44-5
Synonyms: CGP 33101 (Standard); E 2080 (Standard); RUF 331 (Standard)
Research Areas:  

Neurological Disease

Rufinamide (Standard) is the analytical standard of Rufinamide (HY-A0042). This product is intended for research and analytical applications. Rufinamide (CGP 33101) is an orally active antiepileptic compound that inhibits Na + current activation, inhibits neuronal hyperexcitability, and has anticonvulsant effects. Rufinamide is used in the study of Lennox-Gastaut syndrome .
loading...
    loading...
Cat. No.: HY-A0042S
CAS No.: 1129491-38-8
Synonyms: CGP 33101-d2; E 2080-d2; RUF 331-d2
Rufinamide-d2 (CGP 33101-d2) is the deuterium labeled Rufinamide (HY-A0042). Rufinamide (CGP 33101) is an orally active antiepileptic compound that inhibits Na + current activation, inhibits neuronal hyperexcitability, and has anticonvulsant effects. Rufinamide is used in the study of Lennox-Gastaut syndrome .
loading...
    loading...
Cat. No.: HY-A0042S1
CAS No.: 1795037-48-7
Synonyms: CGP 33101-15N,d2; E 2080-15N,d2; RUF 331-15N,d2
Rufinamide- 15N,d2 (CGP 33101- 15N,d2) is the deuterium and 15N labeled Rufinamide (HY-A0042).Rufinamide (CGP 33101) is an orally active antiepileptic compound that inhibits Na + current activation, inhibits neuronal hyperexcitability, and has anticonvulsant effects. Rufinamide is used in the study of Lennox-Gastaut syndrome .
loading...
    loading...
Cat. No.: HY-A0042S2
CAS No.: 2012598-91-1
Synonyms: CGP 33101-15N,d2-1; E 2080-15N,d2-1; RUF 331-15N,d2-1
Rufinamide- 15N,d2-1 (CGP 33101- 15N,d2-1) is 15N- and deuterium-labeled Rufinamide (HY-A0042).Rufinamide (CGP 33101) is an orally active antiepileptic compound that inhibits Na + current activation, inhibits neuronal hyperexcitability, and has anticonvulsant effects. Rufinamide is used in the study of Lennox-Gastaut syndrome .
loading...
    loading...
Cat. No.: HY-110162R
CAS No.: 1259536-62-3
QO 58 (Standard) is the analytical standard of QO 58 (HY-110162). This product is intended for research and analytical applications. QO 58 is a potent modulator of K(v)7 channels. QO-58 increases the current amplitudes, shifts the voltage-dependent activation curve in a more negative direction and slows the deactivation of K(v)7.2/K(v)7.3 currents. QO-58 has the potential for the research of diseases associated with neuronal hyperexcitability .
loading...
    loading...
Cat. No.: HY-182459
CAS No.: 198968-25-1
Target:  

HCN Channel

Research Areas:  

Neurological Disease

Org 34167 freebase is a blood-brain barrier permeable HCN channel modulator. Org 34167 freebase possesses high Caco-2 cell permeability. Org 34167 freebase modulates HCN channel function to alter activation properties and suppress neuronal hyperexcitability. Org 34167 freebase induces tremors in mice at specific doses. Org 34167 freebase acts as a research tool for studies on developmental and epileptic encephalopathies as well as depression .
loading...
    loading...
  • 1